Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	723
Mentorship in the lives of scholars	474
Engineered CAR macrophages target kidney inflammation	399
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	382
Making advance care planning easier for adults with kidney disease and their clinicians	339
The GLP-1 receptor agonist revolution comes to nephrology	339
Role of the gut microbiota in the pathogenesis of IgA nephropathy	338
Disaster preparedness for patients with kidney disease	307
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	256
Uropathogen and host responses in pyelonephritis	247
Designing acute kidney injury clinical trials	223
Kidney health within the broader non-communicable disease agenda	198
Vaccination in patients with kidney failure: lessons from COVID-19	196
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	175
Treatment of chronic kidney disease in older populations	172
A single-cell atlas of DKD treatment responses	171
Daprodustat for anaemia in CKD	159
Roles of sensory receptors in non-sensory organs: the kidney and beyond	157
Beyond state borders: transforming dialysis care for undocumented immigrants	154
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	151
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	149
Genetic determinants of urine and plasma metabolite levels	149
Consideration of sex differences is necessary to achieve health equity	142
Complosome — the intracellular complement system	139
Phosphate sensing via PTC glycolysis	133

Interferon blockade in lupus: effects on antiviral immunity	132
Mutational signatures of ccRCC vary between geographical regions	131
Bringing Pride to nephrology	130
Reducing preventable acute kidney injury in a hospital setting	128
Clonal haematopoiesis and AKI	126
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	126
The effects of sex hormone therapy on kidney function	122
Informing clinical decision making during a pandemic — a call for better preparedness	120
The roles of hyaluronan in kidney development, physiology and disease	118
Menopause and chronic kidney disease	117
Aquaporin water channels: roles beyond renal water handling	116
Increasing diversity and inclusion in nephrology clinical trials	108
Benefits of actin cytoskeleton stabilization	107
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	105
From mapping kidney function to mechanism and prediction	103
Identification of erythropoietin-producing cells	102
NUAK1 promotes kidney fibrosis	100
Design of a renal-sparing antifungal	94
Tertiary lymphoid organs contribute to kidney allograft rejection	93
Heat and health inequity: acting on determinants of health to promote heat justice	92
Treatment of SLE with anti-CD19 CAR-T cells	84
Pathological mechanisms of kidney disease in ageing	83
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	83
Neutrophils and NETs in kidney disease	82
Long-term health outcomes associated with hydration status	78
Salt substitution: opportunities and challenges for nephrology	77
From fat to filter: the effect of adipose tissue-derived signals on kidney function	75
RNA-binding proteins and their role in kidney disease	73
The evolving landscape of immune-mediated glomerular diseases	72
The role of complement in kidney disease	72
Reaping the rewards of mechanistic discovery in glomerular disease	71
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	69
MSC therapy for diabetic kidney disease and nephrotic syndrome	64
Network medicine: an approach to complex kidney disease phenotypes	64
An integrated approach towards a public health perspective on chronic kidney disease	64
A pathway of osmotic stress-induced necroptosis	63
Reducing stress-induced CHOP is renoprotective	63
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	61
A golden year of innovative kidney disease therapeutics	61
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	60
Combination therapy for kidney disease in people with diabetes mellitus	60
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	59
Consequence of microvascular inflammation in transplantation	58
Ketogenic diet benefits in critically ill patients with sepsis	56
The cilia mechanosensation debate gets (bio)physical	53
CKD-specific ASCVD risk prediction tools	53
Transcatheter mitral valve repair in patients with CKD	51
Educating primary healthcare providers about kidney disease	51
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	51
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	50

Consequences of famine and malnourishment on kidney health	49
Kidney complications of parasitic diseases	47
Continuing kidney care in conflicts	47
Role of the cGAS–STING pathway in systemic and organ-specific diseases	46
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	46
Gene therapy in a model of nephrotic syndrome	45
Dietary protection of proximal tubules in diabetes	45
Mechanism of B cell survival in lupus nephritis	45
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	43
Targeting IL-1Ra to attenuate fungal infection	42
Nephrology education and training in Africa	41
Multifaceted innovations needed to advance transplant nephrology	40
Steps forward in the treatment of IgA nephropathy	40
Mannose as a driver of γδ T cell kidney infiltration	40
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	38
Born too soon: lifelong kidney risks and the importance of early intervention	38
The kidney is a novel target of metformin	38
Metabolic alterations in hereditary and sporadic renal cell carcinoma	36
Chronic cardiovascular–kidney disorder: a new conceptual framework	35
Epithelial cell states associated with kidney and allograft injury	35
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	35
Role of necroptosis in kidney health and disease	35
A guide to gene–disease relationships in nephrology	34
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	34
Fasting induces structural and functional changes in the peritoneal membrane	32
A multidisciplinary approach to cardiorespiratory fitness in CKD	32
ALCAM–CD6 in lupus nephritis	32
Author Correction: Therapeutic advances in COVID-19	31
Insights into the impact of pregnancy on kidney disease	31
Derivation of collecting duct organoids	31
Strategies to achieve gender equity in nephrology	29
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	29
Tissue-resident memory T cells in the urogenital tract	28
The increasing burden of mild and moderate anaemia in CKD	28
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	27
Leveraging data as a patient–scientist: frustrations and opportunities	27
The impact of intrauterine growth restriction and prematurity on nephron endowment	27
Renal nerves in physiology, pathophysiology and interoception	27
Fibroblast activation and heterogeneity in fibrotic disease	27
From big data to smart decisions: artificial intelligence in kidney risk assessment	27
Acute kidney injury in patients with burns	26
Switching off SOX9 for epithelial recovery after AKI	26
The perils of misinformation: when health literacy goes awry	26
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	25
Digital determinants of health: opportunities and risks amidst health inequities	25
Crosstalk between glomeruli and tubules	24
CD38 — a new target in renal immune disease	24
Impact of persistent conflict and destabilizing events on dialysis care	22
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	22
Collagen formation, function and role in kidney disease	22
Hope for resistant hypertension through BrigHTN and PRECISION	20
Nephrology and women’s health post-Roe v. Wade: we must do better	19
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	19
Chlorthalidone in advanced CKD	19
The impact of population ageing on the burden of chronic kidney disease	19
The genetics of kidney stone disease and nephrocalcinosis	19
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	18
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	17
Deep learning applications in digital pathology	17
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	16
Pathogenic cellular and molecular mediators in lupus nephritis	16
Cellular senescence: the good, the bad and the unknown	16
Bridging the gap of referral to nephrology care	16
Increased PD1 signalling in kidney ageing	15
Use of kidneys from SARS-CoV-2 infected donors	15
P3H2 in glomerular basement membrane regulation	15
Podocyte-targeted therapies — progress and future directions	15
Anti-tumour antibody-producing plasma cells disseminate from tertiary lymphoid structures	15
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	14
mTORC1 under the control of CB1R	14
Insights into glomerular function and disease pathogenesis	14
New evidence of the impact of mitochondria on kidney health and disease	14
Trained immunity: from kidney failure to organ transplantation	13
Belzutifan: a novel therapy for von Hippel–Lindau disease	13
New and emerging therapies for diabetic kidney disease	12
Vascular damage in systemic lupus erythematosus	12
Progress towards solving the donor organ shortage	12
Advances and challenges in kidney fibrosis therapeutics	12
Thiazides in kidney transplant recipients: skin in the game	11
Important roles of mechanical force and hydraulic pressure in kidney function	11

The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	11
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	11
TRPM channels in health and disease	11
Pharmacogenomics in the clinic	11
Gasdermins and pyroptosis in the kidney	11
SGLT2 inhibitors may prevent diabetes	10
Inflammation and gut dysbiosis as drivers of CKD–MBD	10
Incorporating dementia screening in the care of patients with kidney disease	10
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	10
The impact of the Russian–Ukrainian war for people with chronic diseases	10
Managing climate change risks is imperative for human health	10
Kidney health outcomes of hypertensive disorders of pregnancy	10
Clonal haematopoiesis, ageing and kidney disease	10
Diuretics in patients with chronic kidney disease	9
The genetics and pathogenesis of CAKUT	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Electronic patient-reported outcomes in chronic kidney disease	9
Cell and gene therapy for kidney disease	9
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	8
ECM remodelling by ADAMTS12 in fibrosis	8
The role of lysosomes in metabolic and autoimmune diseases	8
Targeting OSBPL7 restores cholesterol efflux	8
Advancing gender equity to improve kidney care for women: a patient perspective	8
Opioids for chronic pain management in patients with dialysis-dependent kidney failure	8
Patient involvement in nephrology research	8
Progress in xenotransplantation: overcoming immune barriers	7
Youth-onset type 2 diabetes mellitus: an urgent challenge	7
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	7
Epidemiology of haemodialysis outcomes	7
Advances in CRISPR therapeutics	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Disasters and kidney care: pitfalls and solutions	7
Remodelling by macula densa cells	6
Synchronization in the renal microcirculation	6
Long-term lessons from EMPA-KIDNEY	6
A guide to studying 3D genome structure and dynamics in the kidney	6
Circulating osteopontin mediates acute kidney injury-induced respiratory failure	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
The pathogenesis of pre-eclampsia in kidney donors	6
Including sexual orientation and gender identity data to advance nephrology care	6
VISTA dampens T cell activation in injured kidney	6
Intersectionality as a lens for achieving kidney health justice	6
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	6
Paths to organ damage and risk factors in AKI	6
Diagnosis of cardiovascular disease in patients with chronic kidney disease	5
Inequities in kidney health and kidney care	5
Amino acid metabolism in kidney health and disease	5
Drug repurposing for glomerular diseases: an underutilized resource	5
The intelligent podocyte: sensing and responding to a complex microenvironment	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
The catastrophic costs of chronic kidney disease	5
New insights into kidney crosstalk with distant organs	5
Improving nephrology care for people with cognitive impairments and their caregivers	4
Targeting iron uptake to correct T cell dysfunction	4
The kidney stroma in development and disease	4
Iron deficiency of kidney macrophages in CKD	4
Neuroprotective effect of RAS inhibitors	4
UTX regulates accumulation of lipids via kidney serine	4
Sex differences in kidney metabolism and DKD	4
AngII autoantibodies after SARS-CoV-2 infection	4
The roles of tertiary lymphoid structures in chronic diseases	4
Overcoming barriers to deliver high quality kidney care	4
Removal of small, asymptomatic kidney stones	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
A polygenic score predicts CKD across ancestries	4
Ensuring health equity for sexual and/or gender minority individuals	4
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	4
Sexual orientation and gender identity in organ and tissue donation and transplantation	4
Managing RAAS inhibitor use in advanced CKD	3
Nanocapsule system tackles polymyxin B toxicity	3
The pathogenesis of IgA nephropathy and implications for treatment	3
Protein handling in kidney tubules	3
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	3
Leveraging lysine metabolism for renoprotection	3
Macrophages clean out the tubules	3
Targeting perivascular S1P attenuates inflammation	3
Chronic kidney disease screening in LMICs: benefits and challenges	3
The global landscape of kidney registries: immense challenges and unique opportunities	3
Long COVID: long-term health outcomes and implications for policy and research	3
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
Propagation of acute kidney injury	3
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	3
Collagen IV in Gould syndrome and Alport syndrome	3
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants	3
VHL loss attracts immune cells to tumours	3
Targeting APRIL to slow progression of IgA nephropathy	3
Insights into basement membrane complexity	3
Spatial transcriptomics in health and disease	3
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	3
Harnessing plant thylakoids to restore cellular function in AKI	3
NCKs are essential to podocyte–GBM interactions	3
Drivers and mechanisms of cognitive decline in chronic kidney disease	3
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects	3
Author Correction: The immunoregulatory roles of non-haematopoietic cells in the kidney	3